Literature DB >> 20424960

Does irbesartan improve the risk of death or hospitalization for cardiovascular causes among patients with HF and PEF?

JoAnn Lindenfeld1.   

Abstract

Entities:  

Year:  2010        PMID： 20424960     DOI： 10.1007/s11886-010-0099-4

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  4 in total

1.  Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure.

Authors:  Dalane W Kitzman; William C Little; Peter H Brubaker; Roger T Anderson; W Gregory Hundley; Christian T Marburger; Bridget Brosnihan; Timothy M Morgan; Kathryn P Stewart
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

2.  The perindopril in elderly people with chronic heart failure (PEP-CHF) study.

Authors:  John G F Cleland; Michal Tendera; Jerzy Adamus; Nick Freemantle; Lech Polonski; Jacqueline Taylor
Journal:  Eur Heart J       Date:  2006-09-08       Impact factor: 29.983

3.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

4.  Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators.

Authors:  C R Benedict; D H Weiner; D E Johnstone; M G Bourassa; J K Ghali; J Nicklas; P Kirlin; B Greenberg; M A Quinones; S Yusuf
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094
  4 in total
  1 in total

Review 1.  The role of irbesartan in the treatment of patients with hypertension: a comprehensive and practical review.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.